The total return over the past 12 months is -76.97% vs. +16.94% for the S&P 500. So far it's up -68.97% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (76.97%) | (33.31%) | (37.05%) | N/A | N/A | N/A |
| Total Return CAGR | (76.97%) | (33.31%) | (37.05%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Lantern Pharma Inc. (LTRN)
| Year | Start price | End price | LTRN Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $3.03 | $0.94 | (68.97%) | +14.51% | (83.48%) |
| 2025 | $3.19 | $3.03 | (5.02%) | +17.72% | (22.74%) |
| 2024 | $4.28 | $3.19 | (25.47%) | +24.89% | (50.36%) |
| 2023 | $6.04 | $4.28 | (29.14%) | +26.19% | (55.33%) |
| 2022 | $7.98 | $6.04 | (24.31%) | (18.17%) | (6.14%) |
| 2021 | $19.25 | $7.98 | (58.55%) | +28.74% | (87.29%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
